Isoliquiritigenin attenuates LPS-induced AKI by suppression of inflammation involving NF-κB pathway

Septic acute kidney injury (AKI) characterized as acute infection and renal inflammation, still lacks of effective therapies. Isoliquiritigenin (ISL) as a small molecular from licorice, is able to inhibit the expression of HMGB1. However, the role and mechanism of ISL in septic AKI has not been inve...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Transl Res
Autores principales: Tang, Yun, Wang, Chan, Wang, Yanmei, Zhang, Jiong, Wang, Fang, Li, Li, Meng, Xianglong, Li, Guisen, Li, Yi, Wang, Li
Formato: Artigo
Lenguaje:Inglês
Publicado: e-Century Publishing Corporation 2018
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325500/
https://ncbi.nlm.nih.gov/pubmed/30662657
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares